02/21/2026
In the 29th year of the National Ryan White HIV/AIDS Program ( ) Part B AIDS Drug Assistance Program ( ) Monitoring Project, the data reveal a public health system performing at the peak of its clinical potential while navigating an increasingly fragile fiscal environment. Read here: https://nastad.org/2026-rwhap-part-b-adap-monitoring-report
NASTAD is pleased to announce the release of the 2026 National Ryan White HIV/AIDS Program Part B ADAP Monitoring Project Annual Report.
The report highlights the critical role AIDS Drug Assistance Programs (ADAPs) play in supporting access to HIV treatment and improving health outcomes nationwide.
One key finding: In CY2024, ADAP achieved an 87% viral suppression rate among clients served, demonstrating the program’s continued impact in ensuring access to life-saving care.
Stay tuned over the coming weeks as we highlight additional findings and insights from this year’s report.
Read the full report: https://nastad.org/2026-rwhap-part-b-adap-monitoring-report